MD

Business Context and Reporting Period

This summary covers the Form 10-Q filed by MEDNAX, Inc. (Note: The input metadata referenced "Pediatrix," but the filing text identifies the registrant as MEDNAX, Inc.) for the quarterly period ended June 30, 2010. MEDNAX is a large accelerated filer providing physician services through affiliated professional contractors. The company operates a national network of physician practices, primarily in neonatal, maternal-fetal medicine, and pediatric cardiology.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Growth: Revenue increased 9.2% ($29.3 million) for the quarter and 9.4% ($58.3 million) for the six months compared to the prior year. Approximately 76% of this growth was driven by acquisitions completed after the prior comparable period.
• Profitability: Net income rose 14.2% for the quarter and 13.4% for the six months. Operating margins improved slightly to 23.5% (quarter) and 21.4% (six months) due to acquisition growth and administrative efficiencies.
• Expense Management: General and administrative expenses grew slower than revenue (7.9% vs 9.2% for the quarter), improving the expense ratio to 11.2% of revenue.
• Cash Flow: Net cash provided by operating activities decreased to $50.1 million for the six months ended June 30, 2010, from $61.7 million in the prior year. This decline was primarily due to a $70.5 million cash outflow for accounts payable (largely annual incentive compensation payments) and a $14.5 million increase in accounts receivable.
• Acquisitions: The company acquired seven physician group practices for $62.5 million in total consideration during the first half of 2010, recording $59.8 million in goodwill.

Outlook, Risks, and Contingencies

• Regulatory Environment: The "Healthcare Reform Act" enacted in March 2010 introduces changes to fraud laws and payment modifiers. A scheduled 21% Medicare fee reduction was temporarily reversed in June 2010, but a 23% reduction is scheduled for December 1, 2010, unless Congress acts.
• Economic Conditions: The company notes a shift toward government-sponsored programs due to the economic slowdown, which pay less than commercial payors. State budget shortfalls may lead to reduced Medicaid reimbursements.
• Legal Proceedings:
  • Corporate Integrity Agreement: The company is under a five-year agreement with the OIG following a 2006 settlement regarding billing practices. Failure to comply could result in exclusion from federal healthcare programs.
  • Stock Option Review: An ongoing review by the U.S. Attorney's office regarding historical stock option granting practices remains unresolved.
  • Malpractice: The company faces routine medical malpractice claims. It self-insures a portion of this risk, with a total liability of $114.1 million recorded as of June 30, 2010.
• Uncertain Tax Positions: The liability for uncertain tax positions was $50.3 million. The company anticipates this could decrease by up to $11.0 million or increase by $1.0 million over the next 12 months.

Investor Verification Checklist

• Verify the impact of the potential 23% Medicare fee reduction scheduled for December 1, 2010, on future revenue projections.
• Monitor the resolution of the U.S. Attorney's office review regarding historical stock option practices.
• Assess the adequacy of the $114.1 million professional liability reserve given the company's self-insured retention model.
• Review the integration performance of the seven practices acquired in the first half of 2010 to ensure expected synergies are realized.
• Track Days Sales Outstanding (DSO), which increased to 46.7 days, to ensure collection efficiency remains stable despite higher revenue.